Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.

Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP.

J Clin Endocrinol Metab. 2009 Apr;94(4):1162-7. doi: 10.1210/jc.2008-1931. Epub 2008 Dec 30.

PMID:
19116234
2.

Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.

Hughes DT, Miller BS, Cohen MS, Doherty GM, Gauger PG.

Ann Surg Oncol. 2014 May;21(5):1647-52. doi: 10.1245/s10434-013-3467-7. Epub 2014 Jan 3.

PMID:
24385210
3.

Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?

Calò PG, Pisano G, Medas F, Marcialis J, Gordini L, Erdas E, Nicolosi A.

World J Surg Oncol. 2014 May 20;12:152. doi: 10.1186/1477-7819-12-152.

4.

Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.

Byeon HK, Holsinger FC, Tufano RP, Chung HJ, Kim WS, Koh YW, Choi EC.

Ann Surg Oncol. 2014 Nov;21(12):3872-5. doi: 10.1245/s10434-014-3896-y. Epub 2014 Sep 17.

PMID:
25227305
5.

Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.

Pedrazzini L, Baroli A, Marzoli L, Guglielmi R, Papini E.

Minerva Endocrinol. 2013 Sep;38(3):269-79.

PMID:
24126547
6.

Prophylactic lymphadenectomy of neck level II in clinically node-positive papillary thyroid carcinoma.

Koo BS, Seo ST, Lee GH, Kim JM, Choi EC, Lim YC.

Ann Surg Oncol. 2010 Jun;17(6):1637-41. doi: 10.1245/s10434-010-0958-7. Epub 2010 Feb 10.

PMID:
20146100
7.

Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M.

J Clin Endocrinol Metab. 2005 Oct;90(10):5723-9. Epub 2005 Jul 19.

PMID:
16030160
8.

I-123-guided excision of metastatic papillary thyroid cancer.

Khandelwal S, Sener SF, Purdy L, Perlman RM.

J Surg Oncol. 2007 Aug 1;96(2):173-5.

PMID:
17443733
9.
10.

Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm.

Perrino M, Vannucchi G, Vicentini L, Cantoni G, Dazzi D, Colombo C, Rodari M, Chiti A, Beck-Peccoz P, Fugazzola L.

Endocr Relat Cancer. 2009 Mar;16(1):201-10. doi: 10.1677/ERC-08-0119. Epub 2008 Dec 23.

11.

The role of MR imaging in detecting nodal disease in thyroidectomy patients with rising thyroglobulin levels.

Kaplan SL, Mandel SJ, Muller R, Baloch ZW, Thaler ER, Loevner LA.

AJNR Am J Neuroradiol. 2009 Mar;30(3):608-12. doi: 10.3174/ajnr.A1405. Epub 2008 Nov 27.

12.

Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.

Yoo D, Ajmal S, Gowda S, Machan J, Monchik J, Mazzaglia P.

World J Surg. 2012 Jun;36(6):1255-61. doi: 10.1007/s00268-012-1507-2.

PMID:
22430670
13.

The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.

Shindo M, Wu JC, Park EE, Tanzella F.

Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):650-4.

PMID:
16785411
14.

Papillary thyroid cancer: controversies in the management of neck metastasis.

Davidson HC, Park BJ, Johnson JT.

Laryngoscope. 2008 Dec;118(12):2161-5. doi: 10.1097/MLG.0b013e31818550f6.

PMID:
19029855
15.

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.

Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD.

J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.

16.

Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.

Ito Y, Masuoka H, Fukushima M, Inoue H, Kihara M, Tomoda C, Higashiyama T, Takamura Y, Kobayashi K, Miya A, Miyauchi A.

World J Surg. 2010 Jun;34(6):1285-90. doi: 10.1007/s00268-009-0356-0.

PMID:
20041244
17.

The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.

Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB.

Cancer. 1998 Jan 15;82(2):375-88.

PMID:
9445196
18.

Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.

Byeon HK, Ban MJ, Lee JM, Ha JG, Kim ES, Koh YW, Choi EC.

Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16.

PMID:
23070784
19.

Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck.

Koo BS, Choi EC, Park YH, Kim EH, Lim YC.

J Am Coll Surg. 2010 Jun;210(6):895-900. doi: 10.1016/j.jamcollsurg.2010.01.037.

PMID:
20510797
20.

Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.

Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM.

Surgery. 2010 Dec;148(6):1100-6; discussion 1006-7. doi: 10.1016/j.surg.2010.09.019.

PMID:
21134539

Supplemental Content

Support Center